russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLC10.15829/1560-4071-2020-3-3801russjcardiol-3801Research ArticleКЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИCLINICAL GUIDELINESРуководство по диагностике и лечению болезней системы кровообращения в контексте пандемии COVID-19Guidelines for the diagnosis and treatment of circulatory diseases in the context of the COVID-19 pandemichttps://orcid.org/0000-0003-2929-0980ШляхтоЕ ВShlyakhoE. V.

Доктор медицинских наук, профессор, академик РАН, заслуженный деятель науки Российской Федерации, Президент Российского кардиологического общества, главный внештатный специалист кардиолог СЗФО, ЮФО, СКФО, ПФО, главный внештатный специалист-кардиолог Комитета по здравоохранению Правительства Санкт-Петербурга, генеральный директор

Санкт-Петербург

ahleague@mail.ruhttps://orcid.org/0000-0001-8169-7812КонрадиА ОKonradiA. O.

Доктор медицинских наук, профессор, член-корреспондент РАН; заместитель генерального директора по научной работе ФГБУ НМИЦ им. В. А. Алмазова; руководитель НИО артериальной гипертензии; директор Института трансляционной медицины, Университет ИТМО

Санкт-Петербург

ResearcherID: P-1547-2014

ahleague@mail.ruhttps://orcid.org/0000-0002-6645-2515АрутюновГ. П.ArutyunovG. P.

Арутюнов Григорий Павлович — доктор медицинских наук, член-корреспондент РАН, заведующий кафедрой внутренних болезней и общей физиотерапии

Москва

arut@ossn.ruhttps://orcid.org/0000-0003-1180-3549АрутюновА. Г.ArutyunovA. G.

Арутюнов Александр Гртгорьевич — доктор медицинских наук, доцент, профессор кафедры внутренних болезней и общей физиотерапии

Москва

agarutyunov@mail.ruhttps://orcid.org/0000-0001-5031-7637БаутинА ЕBautinA. E.

Доктор медицинских наук, доцент, заведующий НИЛ анестезиологии и реаниматологии

Санкт-Петербург

ahleague@mail.ruhttps://orcid.org/0000-0001-6998-8406БойцовС АBoytsovS. A.

Доктор медицинских наук, профессор, академик РАН, генеральный директор

Москва

ahleague@mail.ruhttps://orcid.org/0000-0001-7652-2962ВиллевальдеС ВVillevaldeS. V.

Доктор медицинских наук, профессор, начальник службы анализа и перспективного планирования Управления по реализации федеральных проектов, заведующий кафедрой кардиологии Факультета подготовки кадров высшей квалификации

ahleague@mail.ruhttps://orcid.org/0000-0001-6795-7884ГригорьеваН. Ю.GrigoryevaN. Yu.

Григорьева Наталья Юрьевна — доктор медицинских наук, доцент, заведующий кафедрой факультетской и поликлинической терапии

Нижний Новгород

 

grigoreva28@mail.ruhttps://orcid.org/0000-0002-6453-2976ДупляковД ВDuplyakovD. V.

Доктор медицинских наук, заместитель главного врача НИИ по медицинской части ГБУЗ Самарский областной клинический кардиологический диспансер им. В. П. Полякова, НИИ кардиологии ФГБОУ ВО Самарский государственный медицинский университет Минздрава России, директор

Самара

ResearcherID: O-5547-2014

ahleague@mail.ruhttps://orcid.org/0000-0001-6533-5950ЗвартауН ЭZvartauN. E.

Кандидат медицинских наук, заместитель генерального директора по работе с регионами, доцент кафедры внутренних болезней Лечебного факультета

Санкт-Петербург

ahleague@mail.ruhttps://orcid.org/0000-0001-7003-5186КозиоловаН. А.KoziolovaN. A.

Козиолова Наталья Андреевна — доктор медицинских наук, профессор, заведующий кафедрой внутренних болезней

Пермь

nakoziolova@mail.ruhttps://orcid.org/0000-0002-2334-1663ЛебедевД СLebedevD. S.

Доктор медицинских наук профессор РАН, з. д.н., руководитель научно-исследовательского отдела аритмологии, профессор кафедры сердечно-сосудистой хирургии

Санкт-Петербург

ahleague@mail.ruhttps://orcid.org/0000-0002-2209-9457МальчиковаС. В.MalchikovaS. V.

Мальчикова Светлана Владимировна — доктор медицинских наук, доцент, профессор кафедры госпитальной терапии

Киров

malchikova@list.ruhttps://orcid.org/0000-0002-5130-5192МедведеваЕ АMedvedevaE. A.

Кандидат медицинских наук, доцент кафедры кардиологии Факультета подготовки кадров высшей квалификации Института медицинского образования, специалист отдела мониторинга и анализа показателей регионального здравоохранения Управления по реализации федеральных проектов, врач-кардиолог консультативно-диагностического центра

ahleague@mail.ruhttps://orcid.org/0000-0002-6553-9141МихайловЕ НMikhailovE. N.

Доктор медицинских наук, руководитель научно-исследовательской лаборатории нейромодуляции научно-исследовательского отдела аритмологии, профессор кафедры сердечно-сосудистой хирургии

ahleague@mail.ruhttps://orcid.org/0000-0002-7817-3847МоисееваО МMoiseevaO. M.

Доктор медицинских наук, профессор, руководитель

ahleague@mail.ruhttps://orcid.org/0000-0002-8160-5612ОрловаЯ. А.OrlovaYa. A.

Орлова Яна Артуровна — доктор медицинских наук, профессор, заведующий кафедрой терапии факультета фундаментальной медицины

Москва

5163002@bk.ruhttps://orcid.org/0000-0003-3301-1577ПавловаТ ВPavlovaT. V.

Доктор медицинских наук, профессор кафедры кардиологии и сердечно-сосудистой хирургии ИПО

Самара

ahleague@mail.ruhttps://orcid.org/0000-0002-5290-0065ПевзнерД ВPevsnerD. V.

Дктор медицинских наук, заведующий блоком интенсивной терапии

Москва

ahleague@mail.ruhttps://orcid.org/0000-0002-8493-0058ПетроваМ. М.PetrovaM. M.

Петрова Марина Михайловна — доктор медицинских наук, профессор, заведующий кафедрой поликлинической терапии, семейной медицины и ЗОЖ с курсом ПО

Красноярск

 

stk99@yandex.ruhttps://orcid.org/0000-0002-3463-7734РебровА. П.RebrovA. P.

Ребров Андрей Петрович — доктор медицинских наук, профессор, заведующий кафедрой госпитальной терапии

Саратов

aprebrov@yandex.ruhttps://orcid.org/0000-0002-0139-5177СитниковаМ ЮSitnikovaM. Yu.

Доктор медицинских наук, профессор, руководитель

Санкт-Петербург

ahleague@mail.ruhttps://orcid.org/0000-0002-0013-0660СоловьеваА ЕSolovyovaA. E.

Кандидат медицинских наук, доцент кафедры кардиологии Факультета подготовки кадров высшей квалификации Института медицинского образования, ведущий специалист службы по развитию регионального здравоохранения Управления по реализации федеральных проектов

ahleague@mail.ruhttps://orcid.org/0000-0002-9659-7010ТарловскаяЕ. И.TarlovskayaE. I.

Тарловская Екатерина Иосифовна — доктор медицинских наук, заведующий кафедрой терапии и кардиологии

Нижний Новгород

etarlovskaya@mail.ruhttps://orcid.org/0000-0003-3597-6794ТрукшинаМ АTrukshinaM. A.

Научный сотрудник научно-исследовательского отдела сердечной недостаточности института сердца и сосудов, врач-кардиолог консультативного диагностического центра

ahleague@mail.ruhttps://orcid.org/0000-0002-7452-1971ФедотовП АFedotovP. A.

Кандидат медицинских наук, ведущий научный сотрудник НИО сердечной недостаточности, заведующий НИЛ высокотехнологичных методов лечения сердечной недостаточности

ahleague@mail.ruhttps://orcid.org/0000-0003-0258-5279ФоминИ. В.FominI. V.

Фомин Игорь Владимирович — доктор медицинских наук, доцент, заведующий кафедрой госпитальной терапии

Нижний Новгород

fomin-i@yandex.ruhttps://orcid.org/0000-0001-6765-2837ХрипунА ВKhripunA. V.

Кандидат медицинских наук, доцент, заместитель главного врача по медицинской части, директор областного сосудистого центра

Ростов-на-Дону

ahleague@mail.ruhttps://orcid.org/0000-0002-9323-592XЧесниковаА. И.ChesnikovaA. I.

Чесникова Анна Ивановна — доктор медицинских наук, профессор, профессор кафедры внутренних болезней № 1

Ростов-на-Дону

rostov-ossn@yandex.ruhttps://orcid.org/0000-0002-7731-7730ШапошникИ. И.ShaposhnikI. I.

Шапошник Игорь Иосифович — доктор медицинских наук, профессор, заведующий кафедрой пропедевтики внутренних болезней

shaposhnik@yandex.ruhttps://orcid.org/0000-0003-2816-1183ЯвеловИ СYavelovI. S.

Доктор медицинских наук, ведущий научный сотрудник отдела клинической кардиологии

Москва

ahleague@mail.ruhttps://orcid.org/0000-0001-5656-3978ЯковлевА НYakovlevA. N.

Кандидат медицинских наук, начальник службы по развитию регионального здравоохранения Управления по реализации федеральных проектов, заведующий научно-исследовательской лабораторией острого коронарного синдрома, доцент кафедры анестезиологии и реаниматологии Лечебного факультета

СанктПетербург

ahleague@mail.ruРоссийское кардиологическое обществоRussian FederationФГБУ НМИЦ им. В. А. Алмазова; Университет ИТМОRussian FederationФГАОУ ВО Российский национальный исследовательский медицинский университет имени Н.И. Пирогова Минздрава РоссииRussian FederationФГБУ НМИЦ им. В. А. Алмазова Минздрава РоссииRussian FederationФГБУ Национальный медицинский исследовательский центр кардиологии Минздрава РоссииRussian FederationИнститут медицинского образованияRussian FederationФГБОУ ВО Приволжский исследовательский медицинский университет Минздрава РоссииRussian FederationГБУЗ Самарский областной клинический кардиологический диспансер им. В. П. Полякова; ФГБОУ ВО Самарский государственный медицинский университет Минздрава РоссииRussian FederationФГБОУ ВО Пермский государственный медицинский университет им. ак. Е.А. Вагнера Минздрава РоссииRussian FederationФГБУ НЦМИЦ им. В. А. Алмазова Минздрава РоссииRussian FederationФГБОУ ВО Кировский государственный медицинский университет Минздрава РоссииRussian FederationНаучно-исследовательского отдел сердечной недостаточностиRussian FederationФГБОУ ВО Московский государственный университет имени М.В. ЛомоносоваRussian FederationФГБОУ ВО Самарский государственный медицинский университет Минздрава РоссииRussian FederationФГБУ НМИЦ кардиологии Минздрава РоссииRussian FederationФГБОУ ВО Красноярский государственный медицинский университет им. профессора В.Ф. Войно-Ясенецкого Минздрава РоссииRussian FederationФГБОУ ВО Саратовский государственный медицинский университет им. В.И. Разумовского Минздрава РоссииRussian FederationНаучно-исследовательский отдел сердечной недостаточностиRussian FederationПриволжский исследовательский медицинский университет Минздрава РоссииRussian FederationГБУ РО РОКБRussian FederationФГБОУ ВО Ростовский государственный медицинский университет Минздрава РоссииRussian FederationФГБОУ ВО Южно-Уральский государственный медицинский университет Минздрава РоссииRussian FederationФГБУ Национальный медицинский исследовательский центр терапии и профилактической медицины Минздрава РоссииRussian Federation20200104202025338013801Copyright © Шляхто Е.В., Конради А.О., Арутюнов Г.П., Арутюнов А.Г., Баутин А.Е., Бойцов С.А., Виллевальде С.В., Григорьева Н.Ю., Дупляков Д.В., Звартау Н.Э., Козиолова Н.А., Лебедев Д.С., Мальчикова С.В., Медведева Е.А., Михайлов Е.Н., Моисеева О.М., Орлова Я.А., Павлова Т.В., Певзнер Д.В., Петрова М.М., Ребров А.П., Ситникова М.Ю., Соловьева А.Е., Тарловская Е.И., Трукшина М.А., Федотов П.А., Фомин И.В., Хрипун А.В., Чесникова А.И., Шапошник И.И., Явелов И.С., Яковлев А.Н., 20202020Шляхто Е.В., Конради А.О., Арутюнов Г.П., Арутюнов А.Г., Баутин А.Е., Бойцов С.А., Виллевальде С.В., Григорьева Н.Ю., Дупляков Д.В., Звартау Н.Э., Козиолова Н.А., Лебедев Д.С., Мальчикова С.В., Медведева Е.А., Михайлов Е.Н., Моисеева О.М., Орлова Я.А., Павлова Т.В., Певзнер Д.В., Петрова М.М., Ребров А.П., Ситникова М.Ю., Соловьева А.Е., Тарловская Е.И., Трукшина М.А., Федотов П.А., Фомин И.В., Хрипун А.В., Чесникова А.И., Шапошник И.И., Явелов И.С., Яковлев А.Н.Shlyakho E.V., Konradi A.O., Arutyunov G.P., Arutyunov A.G., Bautin A.E., Boytsov S.A., Villevalde S.V., Grigoryeva N.Y., Duplyakov D.V., Zvartau N.E., Koziolova N.A., Lebedev D.S., Malchikova S.V., Medvedeva E.A., Mikhailov E.N., Moiseeva O.M., Orlova Y.A., Pavlova T.V., Pevsner D.V., Petrova M.M., Rebrov A.P., Sitnikova M.Y., Solovyova A.E., Tarlovskaya E.I., Trukshina M.A., Fedotov P.A., Fomin I.V., Khripun A.V., Chesnikova A.I., Shaposhnik I.I., Yavelov I.S., Yakovlev A.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/3801

Руководство по диагностике и лечению болезней системы кровообращения в контексте пандемии COVID-19

Guidelines for the diagnosis and treatment of circulatory diseases in the context of the COVID-19 pandemic

COVID-19сердечно-сосудистые заболеванияпрофилактикаострый коронарный синдромCOVID-19cardiovascular diseasespreventionacute coronary syndromeReferences“Product Information. Agenerase (amprenavir).” Glaxo Wellcome, Research Triangle Pk, NC.“Product Information. Agenerase (amprenavir).” Glaxo Wellcome, Research Triangle Pk, NC.“Product Information. Crixivan (indinavir).” Merck & Co, Inc, West Point, PA.“Product Information. Crixivan (indinavir).” Merck & Co, Inc, West Point, PA.“Product Information. Eliquis (apixaban).” Bristol-Myers Squibb Canada Inc, Montreal, IN.“Product Information. Eliquis (apixaban).” Bristol-Myers Squibb Canada Inc, Montreal, IN.“Product Information. Evotaz (atazanavir-cobicistat).” Bristol-Myers Squibb, Princeton, NJ.“Product Information. Evotaz (atazanavir-cobicistat).” Bristol-Myers Squibb, Princeton, NJ.“Product Information. Fortovase (saquinavir)” Roche Laboratories, Nutley, NJ.“Product Information. Fortovase (saquinavir)” Roche Laboratories, Nutley, NJ.“Product Information. Lexiva (fosamprenavir).” GlaxoSmithKline, Research Triangle Park, NC.“Product Information. Lexiva (fosamprenavir).” GlaxoSmithKline, Research Triangle Park, NC.“Product Information. Norvir (ritonavir).” Abbott Pharmaceutical, Abbott Park, IL.“Product Information. Norvir (ritonavir).” Abbott Pharmaceutical, Abbott Park, IL.“Product Information. Prezista (darunavir).” Ortho Biotech Inc, Bridgewater, NJ.“Product Information. Prezista (darunavir).” Ortho Biotech Inc, Bridgewater, NJ.“Product Information. Viracept (nelfinavir).” Agouron Pharma Inc, La Jolla, CA.“Product Information. Viracept (nelfinavir).” Agouron Pharma Inc, La Jolla, CA.“Product Information. Xarelto (rivaroxaban).” Bayer Inc, Toronto, IA.“Product Information. Xarelto (rivaroxaban).” Bayer Inc, Toronto, IA.Баутин А. Е., Мазурок В. А., Осовских В. В., Афанасьева К. Ю. Гемодинамические эффекты маневра мобилизации альвеол у пациентов кардиохирургического профиля с систолической дисфункцией левого желудочка. Анестезиология и реаниматология. 2014; 59(6):43-8.Баутин А. Е., Мазурок В. А., Осовских В. В., Афанасьева К. Ю. Гемодинамические эффекты маневра мобилизации альвеол у пациентов кардиохирургического профиля с систолической дисфункцией левого желудочка. Анестезиология и реаниматология. 2014; 59(6):43-8.Временные методические рекомендации Минздрава России “Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID19)”, версия 4 от 27.03.2020.Временные методические рекомендации Минздрава России “Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID19)”, версия 4 от 27.03.2020.A statement from the International Society of Hypertension on COVID-19. https://ish-world.com/news/a/A-statement-from-the-International-Society-of-Hypertension-onCOVID-19/A statement from the International Society of Hypertension on COVID-19. https://ish-world.com/news/a/A-statement-from-the-International-Society-of-Hypertension-onCOVID-19/Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med. 2016 Jan-Feb;36(1):78-80. doi:10.5144/0256-4947.2016.78.Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med. 2016 Jan-Feb;36(1):78-80. doi:10.5144/0256-4947.2016.78.Alon D, Stein GY, Korenfeld R, Fuchs S. Predictors and outcomes of infection-related hospital admissions of heart failure patients. PLoS One. 2013 Aug 23;8(8):e72476. doi:10.1371/journal.pone.0072476. eCollection 2013.Alon D, Stein GY, Korenfeld R, Fuchs S. Predictors and outcomes of infection-related hospital admissions of heart failure patients. PLoS One. 2013 Aug 23;8(8):e72476. doi:10.1371/journal.pone.0072476. eCollection 2013.Arentz M, Yim E, Klaff L, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020 Mar 19. doi:10.1001/jama.2020.4326. [Epub ahead of print].Arentz M, Yim E, Klaff L, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020 Mar 19. doi:10.1001/jama.2020.4326. [Epub ahead of print].ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak. ASEcho.orgASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak. ASEcho.orgAST Transplantation. COVID 19 Organ Donation and Transplant Town Hall. webinar was recorded on March 23, 2020: https://www.youtube.com/watch?v=LUM8-vDHkI&feature=youtu.beAST Transplantation. COVID 19 Organ Donation and Transplant Town Hall. webinar was recorded on March 23, 2020: https://www.youtube.com/watch?v=LUM8-vDHkI&feature=youtu.beBadawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016 Aug;49:129-33. doi:10.1016/j.ijid.2016.06.015. Epub 2016 Jun 21.Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016 Aug;49:129-33. doi:10.1016/j.ijid.2016.06.015. Epub 2016 Jun 21.Barnes M, Heywood AE, Mahimbo A, et al. Acute myocardial infarction and influenza: a meta-analysis of case-control studies. Heart. 2015;101(21):1738-47. doi:10.1136/heartjnl-2015-307691.Barnes M, Heywood AE, Mahimbo A, et al. Acute myocardial infarction and influenza: a meta-analysis of case-control studies. Heart. 2015;101(21):1738-47. doi:10.1136/heartjnl-2015-307691.Brigham and Women’s Hospital COVID-19 Critical Care Clinical Guidelines. http://www.covidprotocols.org/Brigham and Women’s Hospital COVID-19 Critical Care Clinical Guidelines. http://www.covidprotocols.org/Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801-9.Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801-9.Brozovic M, Gurd LJ. Prothrombin during warfarin treatment. Br J Haematol. 1973;24:579-88.Brozovic M, Gurd LJ. Prothrombin during warfarin treatment. Br J Haematol. 1973;24:579-88.BSE Clinical guidance regarding provision of echocardiography during the COVID-19 pandemic. www.bsecho.orgBSE Clinical guidance regarding provision of echocardiography during the COVID-19 pandemic. www.bsecho.orgCerner Multum, Inc. “Australian Product Information.” O 0Cerner Multum, Inc. “Australian Product Information.” O 0Cerner Multum, Inc. “UK Summary of Product Characteristics.” O 0Cerner Multum, Inc. “UK Summary of Product Characteristics.” O 0Cerner Multum, Inc. “UK Summary of Product Characteristics.” O 0Cerner Multum, Inc. “UK Summary of Product Characteristics.” O 0Chan JWM, Ng CK, Chan YH, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax. 2003;58:686-689.Chan JWM, Ng CK, Chan YH, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax. 2003;58:686-689.Chen C, Zhou Y, Wang DW. ARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020; Mar 5. doi:10.1007/s00059-020-04909-z.Chen C, Zhou Y, Wang DW. ARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020; Mar 5. doi:10.1007/s00059-020-04909-z.Chen C, Chen C, Yan JT et al. Analysis of myocardial injury in patients with COVID19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Mar 6;48(0):E008. doi:10.3760/cma.j.cn112148-20200225-00123.Chen C, Chen C, Yan JT et al. Analysis of myocardial injury in patients with COVID19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Mar 6;48(0):E008. doi:10.3760/cma.j.cn112148-20200225-00123.Choi AD, Abbara S, Branch KR, et al. SCCT Guidance for Use of Cardiac Computed Tomography Amidst the COVID-19 Pandemic. J Cardiovasc Comput Tomogr. 2016 Nov — Dec;10(6):435-49. doi:10.1016/j.jcct.2016.10.002.Choi AD, Abbara S, Branch KR, et al. SCCT Guidance for Use of Cardiac Computed Tomography Amidst the COVID-19 Pandemic. J Cardiovasc Comput Tomogr. 2016 Nov — Dec;10(6):435-49. doi:10.1016/j.jcct.2016.10.002.Coronavirus: COVID-19 Information for transplant professionals. https://bts.org.uk/wp-content/uploads/2020/03/Coronavirus-transplant-information-25th-March-2020.pdfCoronavirus: COVID-19 Information for transplant professionals. https://bts.org.uk/wp-content/uploads/2020/03/Coronavirus-transplant-information-25th-March-2020.pdfDarlington MR. Hypoprothrombinemia during concomitant therapy with warfarin and saquinavir. Ann Pharmacother. 1997 May;31(5):647.Darlington MR. Hypoprothrombinemia during concomitant therapy with warfarin and saquinavir. Ann Pharmacother. 1997 May;31(5):647.Elkind MS, Harrington RA, Benjamin IJ. Role of the American Heart Association in the Global COVID-19 Pandemic. Circulation. 2020 Mar 17. doi:10.1161/CIRCULATIONAHA.120.046749. [Epub ahead of print].Elkind MS, Harrington RA, Benjamin IJ. Role of the American Heart Association in the Global COVID-19 Pandemic. Circulation. 2020 Mar 17. doi:10.1161/CIRCULATIONAHA.120.046749. [Epub ahead of print].Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020 Mar 11. pii:S22132600(20)30116-8. doi:10.1016/S2213-2600(20)30116-8. [Epub ahead of print].Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020 Mar 11. pii:S22132600(20)30116-8. doi:10.1016/S2213-2600(20)30116-8. [Epub ahead of print].Ferrario CM, Jessup J, Gallagher PE, et al. Effects of renin-angiotensin system blockage on renal angiotensin-(1-7) forming enzymes and receptors. Kidney Int., 2005;68:2189-96.Ferrario CM, Jessup J, Gallagher PE, et al. Effects of renin-angiotensin system blockage on renal angiotensin-(1-7) forming enzymes and receptors. Kidney Int., 2005;68:2189-96.Frederik GPW, Shah PB, Aronow HD, et al. Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC’s Interventional Council and SCAI. JACC, March 2020. doi:10.1016/j.jacc.2020.03.021.Frederik GPW, Shah PB, Aronow HD, et al. Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC’s Interventional Council and SCAI. JACC, March 2020. doi:10.1016/j.jacc.2020.03.021.Gao Y. Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID-19. J Med Virol. 2020 Mar 17. doi:10.1002/jmv.25770.Gao Y. Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID-19. J Med Virol. 2020 Mar 17. doi:10.1002/jmv.25770.Gatti G, Alessandrini A, Camera M, et al. Influence of indinavir and ritonavir on warfarin anticoagulant activity. AIDS. 1998;12:825-6.Gatti G, Alessandrini A, Camera M, et al. Influence of indinavir and ritonavir on warfarin anticoagulant activity. AIDS. 1998;12:825-6.Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy. JAMA 2020. Published Online 13.03.2020. doi:10.1001/jama.2020.4031.Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy. JAMA 2020. Published Online 13.03.2020. doi:10.1001/jama.2020.4031.Guan W-j, Ni Z-y, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New Eng J Med. February 28, 2020; doi:10.1056/NEJMoa2002032. [Epub ahead of print].Guan W-j, Ni Z-y, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New Eng J Med. February 28, 2020; doi:10.1056/NEJMoa2002032. [Epub ahead of print].Hamblin TJ Interaction between warfarin and phenformin. Lancet. 1971 Dec 11;2(7737):1323. doi:10.1016/s0140-6736(71)90650-7.Hamblin TJ Interaction between warfarin and phenformin. Lancet. 1971 Dec 11;2(7737):1323. doi:10.1016/s0140-6736(71)90650-7.Hansen RA, Tu W, Wang J, Ambuehl R, et al. Risk of adverse gastrointestinal events from inhaled corticosteroids. Pharmacotherapy 2008;28:1325-34. doi:10.1592/phco.28.11.1325.Hansen RA, Tu W, Wang J, Ambuehl R, et al. Risk of adverse gastrointestinal events from inhaled corticosteroids. Pharmacotherapy 2008;28:1325-34. doi:10.1592/phco.28.11.1325.HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID19 https://www.acc.org/latest-in-cardiology/articles/2020/03/17/08/59/hfsa-acc-ahastatementaddresses-concerns-re-using-raas-antagonists-in-covid-19.HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID19 https://www.acc.org/latest-in-cardiology/articles/2020/03/17/08/59/hfsa-acc-ahastatementaddresses-concerns-re-using-raas-antagonists-in-covid-19.http://www.chinacdc.cn/en/COVID19.http://www.chinacdc.cn/en/COVID19.http://www.covid19-druginteractions.org.http://www.covid19-druginteractions.org.https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6.https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6.https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/18016/donationinternationalreflections-17032020.pdf.https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/18016/donationinternationalreflections-17032020.pdf.https://pubs.rsna.org/doi/pdf/10.1148/radiol.2020200847.https://pubs.rsna.org/doi/pdf/10.1148/radiol.2020200847.https://www.acc.org/latest-in-cardiology/articles/2020/03/18/15/25/troponin-and-bnpusein-covid19.https://www.acc.org/latest-in-cardiology/articles/2020/03/18/15/25/troponin-and-bnpusein-covid19.https://www.ema.europa.eu/en/documents/press-release/ema-gives-advice-use-nonsteroidalanti-inflammatories-covid-19_en.pdf.https://www.ema.europa.eu/en/documents/press-release/ema-gives-advice-use-nonsteroidalanti-inflammatories-covid-19_en.pdf.https://www.heart.org/en/about-us/coronavirus-covid-19-resources, дата обращения 18.03.2020.https://www.heart.org/en/about-us/coronavirus-covid-19-resources, accessed on 18.03.2020.https://www.journalofcardiovascularct.com/article/S1934-5925(20)30125-8/pdf.https://www.journalofcardiovascularct.com/article/S1934-5925(20)30125-8/pdf.https://www.medrxiv.org/content/10.1101/2020.02.29.20027698v2, https://medium.com/@nigam/higher-co-infection-rates-in-covid19-b24965088333.https://www.medrxiv.org/content/10.1101/2020.02.29.20027698v2, https://medium.com/@nigam/higher-co-infection-rates-in-covid19-b24965088333.https://www.thelancet.com/action/showPdf?pii=S2213-2600%2820%2930120-X.https://www.thelancet.com/action/showPdf?pii=S2213-2600%2820%2930120-X.Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2020 Mar 16. pii: ehaa190. doi:10.1093/eurheartj/ehaa190. [Epub ahead of print].Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2020 Mar 16. pii: ehaa190. doi:10.1093/eurheartj/ehaa190. [Epub ahead of print].Hui H, Zhang Y, Yang X, et al. Clinical and radiographic features of cardiac injury in patients with 2019 novel coronavirus pneumonia. Medrxiv.org, posted 27.02.2020. doi:10.1101/2020.02.24.20027052.Hui H, Zhang Y, Yang X, et al. Clinical and radiographic features of cardiac injury in patients with 2019 novel coronavirus pneumonia. Medrxiv.org, posted 27.02.2020. doi:10.1101/2020.02.24.20027052.Hypertension Canada’s Statement on: Hypertension, ACE-Inhibitors and Angiotensin Receptor Blockers and COVID-19. https://hypertension.ca/wp-content/uploads/2020/03/2020-30-15-Hypertension-Canada-Statement-on-COVID-19-ACEi-ARB.pdf.Hypertension Canada’s Statement on: Hypertension, ACE-Inhibitors and Angiotensin Receptor Blockers and COVID-19. https://hypertension.ca/wp-content/uploads/2020/03/2020-30-15-Hypertension-Canada-Statement-on-COVID-19-ACEi-ARB.pdf.Itkonen MK, Tornio A, Lapatto-Reiniluoto O, et al. Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel. Clin Pharmacol Ther. 2019 Jan;105(1):219-228. doi:10.1002/cpt.1099. Epub 2018 Aug 9.Itkonen MK, Tornio A, Lapatto-Reiniluoto O, et al. Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel. Clin Pharmacol Ther. 2019 Jan;105(1):219-228. doi:10.1002/cpt.1099. Epub 2018 Aug 9.Knoell KR, Young TL, Cousins ES. Potential interaction involving warfarin and ritonavir. Ann Pharmacother. 1998;32:1299-302. doi:10.1345/aph.17456Knoell KR, Young TL, Cousins ES. Potential interaction involving warfarin and ritonavir. Ann Pharmacother. 1998;32:1299-302. doi:10.1345/aph.17456Koch-Weser J, Sellers EM. Drug interactions with coumarin anticoagulants (second of two parts). N Engl J Med. 1971;285:547-58. doi:10.1056/NEJM197109022851005Koch-Weser J, Sellers EM. Drug interactions with coumarin anticoagulants (second of two parts). N Engl J Med. 1971;285:547-58. doi:10.1056/NEJM197109022851005Ku LL, Ward CO, Durgin SJ. A clinical study of drug interaction and anticoagulant therapy. Drug Intell Clin Pharm. 1970;4:300-6.Ku LL, Ward CO, Durgin SJ. A clinical study of drug interaction and anticoagulant therapy. Drug Intell Clin Pharm. 1970;4:300-6.Kwong JC, Schwartz KL, Campitelli MA, et al. Acute myocardial infarction after laboratoryconfirmed influenza infection. N Engl J Med. 2018 Jan 25;378(4):345-353. doi:10.1056/NEJMoa1702090.Kwong JC, Schwartz KL, Campitelli MA, et al. Acute myocardial infarction after laboratoryconfirmed influenza infection. N Engl J Med. 2018 Jan 25;378(4):345-353. doi:10.1056/NEJMoa1702090.Lauer SA, Grantz KH, Bi Q, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. March 10, 2020. doi:10.7326/M20-0504. [Epub ahead of print].Lauer SA, Grantz KH, Bi Q, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. March 10, 2020. doi:10.7326/M20-0504. [Epub ahead of print].Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol (2020). doi:10.1007/s00392-020-01626-9.Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol (2020). doi:10.1007/s00392-020-01626-9.Liu K, Fang YY, Deng Y, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl) 2020. Feb 7. doi:10.1097/CM9.0000000000000744.Liu K, Fang YY, Deng Y, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl) 2020. Feb 7. doi:10.1097/CM9.0000000000000744.Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020 Mar;63(3):364-374. doi:10.1007/s11427-020-1643-8. Epub 2020 Feb 9.Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020 Mar;63(3):364-374. doi:10.1007/s11427-020-1643-8. Epub 2020 Feb 9.Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19 The Lancet Infect Dis. 19, 2020. doi:10.1016/S1473-3099(20)30232-2.Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19 The Lancet Infect Dis. 19, 2020. doi:10.1016/S1473-3099(20)30232-2.Llibre JM, Romeu J, Lopez E, Sirera G “Severe interaction between ritonavir and acenocoumarol.” Ann Pharmacother 36 (2002):621-3. doi:10.1345/aph.19361.Llibre JM, Romeu J, Lopez E, Sirera G “Severe interaction between ritonavir and acenocoumarol.” Ann Pharmacother 36 (2002):621-3. doi:10.1345/aph.19361.Mahmud E. The Evolving Pandemic of COVID-19 and Interventional Cardiology. Position of President of Society for Cardiovascular Angiography & Interventions. www.scai.org,16.03.2020.Mahmud E. The Evolving Pandemic of COVID-19 and Interventional Cardiology. Position of President of Society for Cardiovascular Angiography & Interventions. www.scai.org,16.03.2020.Marsousi N, Daali Y, Fontana P et al. Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites. Clin Pharmacokinet. 2018 Oct;57(10):1347-1354. doi:10.1007/s40262-018-0637-6.Marsousi N, Daali Y, Fontana P et al. Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites. Clin Pharmacokinet. 2018 Oct;57(10):1347-1354. doi:10.1007/s40262-018-0637-6.Mehra MR, Ruschitzka F. COVID-19 Illness and Heart Failure: A Missing Link? JACC: Heart Failure. 2020: doi:10.1016/j.jchf.2020.03.004.Mehra MR, Ruschitzka F. COVID-19 Illness and Heart Failure: A Missing Link? JACC: Heart Failure. 2020: doi:10.1016/j.jchf.2020.03.004.Moriarty LF, Plucinski MM, Marston BJ, et al. Public health responses to Covid-19 outbreaks on cruise ships — worldwide, February-March. MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):347-52. doi:10.15585/mmwr.mm6912e3.Moriarty LF, Plucinski MM, Marston BJ, et al. Public health responses to Covid-19 outbreaks on cruise ships — worldwide, February-March. MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):347-52. doi:10.15585/mmwr.mm6912e3.Newshan G, Tsang P. Ritonavir and warfarin interaction. AIDS. 1999;13:1788-9. doi:10.1097/00002030-199909100-00028.Newshan G, Tsang P. Ritonavir and warfarin interaction. AIDS. 1999;13:1788-9. doi:10.1097/00002030-199909100-00028.Nguyen JL, Yang W, Ito K, et al. Seasonal Influenza Infections and Cardiovascular Disease Mortality. JAMA Cardiol. 2016 Jun 1;1(3):274-81. doi:10.1001/jamacardio.2016.0433.Nguyen JL, Yang W, Ito K, et al. Seasonal Influenza Infections and Cardiovascular Disease Mortality. JAMA Cardiol. 2016 Jun 1;1(3):274-81. doi:10.1001/jamacardio.2016.0433.NHSBT/BTS guidance for clinicians on consent for solid organ transplantation in adults and living organ donation in the context of the COVID-19 pandemic. https://bts.org.uk/wp-content/uploads/2020/03/NHSBT-BTS-consent-guidance-COVID-19-26.3.20.pdf.NHSBT/BTS guidance for clinicians on consent for solid organ transplantation in adults and living organ donation in the context of the COVID-19 pandemic. https://bts.org.uk/wp-content/uploads/2020/03/NHSBT-BTS-consent-guidance-COVID-19-26.3.20.pdf.Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID19) in China [Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 17;41(2):145-151. doi:10.3760/cma.j.issn.0254-6450.2020.02.003. [Epub ahead of print]Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID19) in China [Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 17;41(2):145-151. doi:10.3760/cma.j.issn.0254-6450.2020.02.003. [Epub ahead of print]Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. March 23, 2020; doi:10.1001/jama.2020.4683. Published online.Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. March 23, 2020; doi:10.1001/jama.2020.4683. Published online.Park JH, Balmain S, Berry C, et al. Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction. Heart. 2010 Apr;96(7):533-8. doi:10.1136/hrt.2009.175257.Park JH, Balmain S, Berry C, et al. Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction. Heart. 2010 Apr;96(7):533-8. doi:10.1136/hrt.2009.175257.Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016 Aug;18(8):891-975. doi:10.1002/ejhf.592. Epub 2016 May 20.Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016 Aug;18(8):891-975. doi:10.1002/ejhf.592. Epub 2016 May 20.Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers. https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-angPosition Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers. https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-angPrescribing information. Brilinta (ticagrelor). Wilmington, DE: AstraZeneca LP, 07/2011.Prescribing information. Brilinta (ticagrelor). Wilmington, DE: AstraZeneca LP, 07/2011.Prioritisation of Heart Failure Service Provision During Covid-19. https://www.bsh.org.uk/2020/03/19/prioritisation-of-heart-failure-service-provision-during-covid-19.Prioritisation of Heart Failure Service Provision During Covid-19. https://www.bsh.org.uk/2020/03/19/prioritisation-of-heart-failure-service-provision-during-covid-19.Product monograph. Brilinta (ticagrelor). Mississauga, Ontario, Canada: AstraZeneca CanadaInc., May 2011.Product monograph. Brilinta (ticagrelor). Mississauga, Ontario, Canada: AstraZeneca CanadaInc., May 2011.Putot А, Chague F, Manckoundia P, on behalf of RICO Survey. Post-Infectious Myocardial Infarction: New Insights for Improved Screening. J Clin Med. 2019;8(6):827. doi:10.3390/jcm8060827.Putot А, Chague F, Manckoundia P, on behalf of RICO Survey. Post-Infectious Myocardial Infarction: New Insights for Improved Screening. J Clin Med. 2019;8(6):827. doi:10.3390/jcm8060827.Rivar MB, Bajwa EK, Januzzi JL, et al. Prognostic significance of elevated cardiac troponinT levels in acute respiratory distress syndrome patients. PLoS One. 2012;7(7):e40515. doi:10.1371/journal.pone.0040515.Rivar MB, Bajwa EK, Januzzi JL, et al. Prognostic significance of elevated cardiac troponinT levels in acute respiratory distress syndrome patients. PLoS One. 2012;7(7):e40515. doi:10.1371/journal.pone.0040515.Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020; Mar 3. doi:10.1007/s00134-020-05991-x.Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020; Mar 3. doi:10.1007/s00134-020-05991-x.Sandau KE, Funk M, Auerbach A, et al. Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association. Circulation. 2017 Nov 7;136(19):e273-e344. doi:10.1161/CIR.0000000000000527.Sandau KE, Funk M, Auerbach A, et al. Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association. Circulation. 2017 Nov 7;136(19):e273-e344. doi:10.1161/CIR.0000000000000527.Sawamura A, Okumura T, Ito M, et al, Investigators CP. Prognostic value of electrocardiography in patients with fulminant myocarditis supported by percutaneous venoarterial extracorporeal membrane oxygenationanalysis from the CHANGE PUMP study. Circ J. 2018 Jul 25;82(8):2089-95. doi:10.1253/circj.CJ-18-0136.Sawamura A, Okumura T, Ito M, et al, Investigators CP. Prognostic value of electrocardiography in patients with fulminant myocarditis supported by percutaneous venoarterial extracorporeal membrane oxygenationanalysis from the CHANGE PUMP study. Circ J. 2018 Jul 25;82(8):2089-95. doi:10.1253/circj.CJ-18-0136.Schumann J, Henrich EC, Strobl H, et al. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev. 2018 Jan 29;1:CD009669. doi:10.1002/14651858.CD009669.pub3.Schumann J, Henrich EC, Strobl H, et al. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev. 2018 Jan 29;1:CD009669. doi:10.1002/14651858.CD009669.pub3.Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12 — March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-6. doi:10.15585/mmwr.mm6912e2.Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12 — March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-6. doi:10.15585/mmwr.mm6912e2.Stading JA. Effects of prednisone on the International Normalized Ratio. Am J Health Syst Pharm. 2006;63:2354-6. doi:10.2146/ajhp060105Stading JA. Effects of prednisone on the International Normalized Ratio. Am J Health Syst Pharm. 2006;63:2354-6. doi:10.2146/ajhp060105Statement of the European Society of Hypertension (ESH) on hypertension, Renin Angiotensin System blockers and COVID-19. https://www.eshonline.org/spotlights/esh-stabtement-on-covid-19.Statement of the European Society of Hypertension (ESH) on hypertension, Renin Angiotensin System blockers and COVID-19. https://www.eshonline.org/spotlights/esh-stabtement-on-covid-19.Suzuki T, Koga H, Yamazaki S, et al. Probable interaction between warfarin and antitumor agents used in R-ESHAP chemotherapy. Clin Ther. 2008 Jun;30(6):1155-9. doi:10.1016/j.clinthera.2008.06.008.Suzuki T, Koga H, Yamazaki S, et al. Probable interaction between warfarin and antitumor agents used in R-ESHAP chemotherapy. Clin Ther. 2008 Jun;30(6):1155-9. doi:10.1016/j.clinthera.2008.06.008.van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Mar 17. doi:10.1056/NEJMc2004973. [Epub ahead of print].van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Mar 17. doi:10.1056/NEJMc2004973. [Epub ahead of print].Veronese G, Ammirati E, Cipriani M, Frigerio M. Fulminant myocarditis: Characteristics, treatment, and outcomes. Anatol J Cardiol. 2018 Apr;19(4):279-286. doi:10.14744/AnatolJCardiol.2017.8170. Epub 2018 Mar 13.Veronese G, Ammirati E, Cipriani M, Frigerio M. Fulminant myocarditis: Characteristics, treatment, and outcomes. Anatol J Cardiol. 2018 Apr;19(4):279-286. doi:10.14744/AnatolJCardiol.2017.8170. Epub 2018 Mar 13.Wadman B, Werner I. Thromboembolic complications during corticosteroid treatment of temporal arteritis. Lancet. 1972 Apr 22;1(7756):907. doi:10.1016/s0140-6736(72)90784-2.Wadman B, Werner I. Thromboembolic complications during corticosteroid treatment of temporal arteritis. Lancet. 1972 Apr 22;1(7756):907. doi:10.1016/s0140-6736(72)90784-2.Wakai A, McCabe A, Kidney R, et al. Nitrates for acute heart failure syndromes. Cochrane Database Syst Rev. 2013 Aug 6;(8):CD005151. doi:10.1002/14651858.CD005151.pub2.Wakai A, McCabe A, Kidney R, et al. Nitrates for acute heart failure syndromes. Cochrane Database Syst Rev. 2013 Aug 6;(8):CD005151. doi:10.1002/14651858.CD005151.pub2.Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA. 2020. doi:10.1001/jama.2020.1585.Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA. 2020. doi:10.1001/jama.2020.1585.Wang YH, Zhang GH, Zhang LL, et al. Adrenal hemorrhage in a patient with systemic lupus erythematosus. Beijing Da Xue Xue Bao Yi Xue Ban. 2019 Dec 18;51(6):1178-81.Wang YH, Zhang GH, Zhang LL, et al. Adrenal hemorrhage in a patient with systemic lupus erythematosus. Beijing Da Xue Xue Bao Yi Xue Ban. 2019 Dec 18;51(6):1178-81.Watkins J. Preventing a covid-19 pandemic. BMJ. 2020;m810. doi:10.1136/bmj.m810.Watkins J. Preventing a covid-19 pandemic. BMJ. 2020;m810. doi:10.1136/bmj.m810.Weng C-L, Zhao Y-T, Liu Q-H, et al. Meta-analysis: noninvasive ventilation in acute cardiogenic pulmonary edema. Ann Intern Med. 2010 May 4;152(9):590-600. doi:10.7326/0003-4819-152-9-201005040-00009.Weng C-L, Zhao Y-T, Liu Q-H, et al. Meta-analysis: noninvasive ventilation in acute cardiogenic pulmonary edema. Ann Intern Med. 2010 May 4;152(9):590-600. doi:10.7326/0003-4819-152-9-201005040-00009.WHO Coronavirus disease 2019 (COVID-19). Situation Report–41. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200301-sitrep-41-covid-19.pdf?sfvrsn=6768306d_2.WHO Coronavirus disease 2019 (COVID-19). Situation Report–41. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200301-sitrep-41-covid-19.pdf?sfvrsn=6768306d_2.World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID19). Geneva: WHO; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/whochina-joint-mission-on-covid-19-final-report.pdf]World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID19). Geneva: WHO; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/whochina-joint-mission-on-covid-19-final-report.pdf]Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. Published online February 24, 2020. doi:10.1001/jama.2020.2648.Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. Published online February 24, 2020. doi:10.1001/jama.2020.2648.Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications European Heart Journal. Published online 18 March 2020. doi:10.1093/eurheartj/ehaa231.Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications European Heart Journal. Published online 18 March 2020. doi:10.1093/eurheartj/ehaa231.Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Feb 18. pii:S2213-2600(20)30076-X.Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Feb 18. pii:S2213-2600(20)30076-X.Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis, International Journal of Infectious Diseases (2020). doi:10.1016/j.ijid.2020.03.017.Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis, International Journal of Infectious Diseases (2020). doi:10.1016/j.ijid.2020.03.017.Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARSCoV2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 Feb 24. pii:S2213-2600(20)30079-5. doi:10.1016/S22132600(20)30079-5. [Epub ahead of print].Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARSCoV2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 Feb 24. pii:S2213-2600(20)30079-5. doi:10.1016/S22132600(20)30079-5. [Epub ahead of print].Zeng J, Huang J, Pan L. How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People’s Hospital. Intensive Care Med 2020. doi:10.1007/s00134-020-05993-9.Zeng J, Huang J, Pan L. How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People’s Hospital. Intensive Care Med 2020. doi:10.1007/s00134-020-05993-9.Zheng Y, Ma Y, Zhang J, et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020 Mar 5. doi:10.1038/s41569-020-0360-5. [Epub ahead of print].Zheng Y, Ma Y, Zhang J, et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020 Mar 5. doi:10.1038/s41569-020-0360-5. [Epub ahead of print].Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-62. doi:10.1016/S0140-6736(20)30566-3.Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-62. doi:10.1016/S0140-6736(20)30566-3.Zhu ZW, Tang JJ, Chai XP, et al. Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics. Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Mar 4;48(0):E007. doi:10.3760/cma.j.cn112148-20200218-00093. [Epub ahead of print].Zhu ZW, Tang JJ, Chai XP, et al. Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics. Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Mar 4;48(0):E007. doi:10.3760/cma.j.cn112148-20200218-00093. [Epub ahead of print].

The authors declare that there are no conflicts of interest present.